Evaluation of CXCL10, CXCL11, CXCL12 and CXCL13 chemokines in serum and cerebrospinal fluid in patients with tick borne encephalitis (TBE)

Advances in Medical Sciences

Volumn 56, Issue 2, 2011, Pages 311-317

  Zajkowska, J ^a   Moniuszko Malinowska, A ^a   Pancewicz, S ^a   Muszynska Mazur A ^a   Kondrusik, M ^a   Grygorczuk, S ^a   Swierzbinska Pijanowska R ^a   Dunaj, J ^a   Czupryna, P ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

CXCL10; CXCL11; CXCL12; CXCL13; tick borne encephalitis

Indexed keywords

CXCL11 CHEMOKINE; CXCL13 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; STROMAL CELL DERIVED FACTOR 1;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MOLECULAR DIAGNOSIS; NERVOUS SYSTEM INFLAMMATION; PATIENT MONITORING; POLAND; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; TICK BORNE ENCEPHALITIS; UNIVERSITY HOSPITAL;

EID: 84855454503     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.2478/v10039-011-0033-z     Document Type: Article

References (24)

1. Baggiolini M. Chemokines in pathology and medicine. J Intern Med. 2001 Aug;250(2):91-104. (Pubitemid 32868689)
2. Baggiolini M. Chemokines and leukocyte traffc. Nature. 1998 Apr 9;392(6676):565-8.
3. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in infammation. N Engl J Med. 2006 Feb 9;354(6):610-21. (Pubitemid 43209108)
4. Cartier L, Hartley O, Dubois-Dauphin M, Krause KH. Chemokine receptors in the central nervous system: role in brain infammation and neurodegenerative diseases. Brain Res Brain Res Rev. 2005 Feb;48(1):16-42. (Pubitemid 40215781)
5. Grygorczuk S, Pancewicz S, Kondrusik M, Zajkowska J, Hermanowska- Szpakowicz T. Chemokiny w zapaleniach opon mózgowo-rdzeniowych o róznej etiologii [Chemokines of meningitis of different ethiologies]. Pol Merkur Lekarski. 2001 Feb; 10(56):117-21. Polish.
6. Kunz Ch. Tick-borne encephalitis in Europe. Acta Leiden. 1992;60(2):1-14.
7. Gelpi E, Preusser M, Laggner U, Garzuly F, Holzmann H, Heinz FX, Budka H. Infammatory response in human tick-borne encephalitis: analysis of postmortem brain tissue. J Neurovirol. 2006 Aug;12(4):322-7. (Pubitemid 44382983)
8. Bechtel U, Scheuer R, Landgraf R, König A, Feucht HE. Assessment of soluble adhesion molecules (sICAM-1, sVCAM-1, sELAM-1) and complement cleavage products (sC4d, sC5b-9) in urine. Clinical monitoring of renal allograft recipients. Transplantation. 1994 Oct 27;58(8):905-11. (Pubitemid 24333281)
9. Bhowmick S, Duseja R, Das S, Appaiahgiri MB, Vrati S, Basu A. Induction of IP-10 (CXCL10) in astrocytes following Japanese encephalitis. Neurosci Lett. 2007 Feb 27;414(1):45-50. (Pubitemid 46241638)
10. Biber K, Zuurman MW, Dijkstra IM, Boddeke HW. Chemokines in the brain: neuroimmunology and beyond. Curr Opin Pharmacol. 2002 Feb;2(1):63-8.
11. Mickiené A, Laikonis A, Günther G, Vene S, Lundkvist A, Lindquist L. Tick-borne encephalitis in area of high endemicity in Lithuania: disease severity and long-term prognosis. Clin Infect Dis. 2002 Sep 15; 35(6):650-8. (Pubitemid 35024723)
12. Haglund M, Günther G. Tick-borne encephalitis-pathogenesis, clinical course and long-term follow-up. Vaccine. 2003 Apr 1; 21 Suppl 1:S11-8.
13. Dumpis U, Crook D, Oksi J. Tick-borne encephalitis. Clin Infect Dis. 1999 Apr; 28(4):882-90. (Pubitemid 29169431)
14. Holub M, Kluckova Z, Beran O, Aster V, Lobovská A. Lymphocyte subset numbers in cerebrospinal fuid: comparison of tick-borne encephalitis and neuroboreliosis. Acta Neurol Scand. 2002 Nov;106(5):302-8. (Pubitemid 35177999)
15. Lepej SZ, Misic-Majerus L, Jeren T, Rode OD, Remenar A, Sporec V, Vince A. Chemokines CXCL10 and CXCL11 in the cerebrospinal fuid of patients with tick-borne encephalitis. Acta Neurol Scand. 2007 Feb;115(2):109-14. (Pubitemid 46018546)
16. Lepej SZ, Rode OD, Jeren T, Vince A, Remenar A, Barsic B. Increased expression of CXCR3 and CCR5 on memory CD4+ T-cells migrating into the cerebrospinal fuid of patients with neuroborreliosis: the role of CXCL 10 and CXCL11. J Neuroimmunol. 2005 Jun;163(1-2):128-34. (Pubitemid 40692956)
17. Lahrtz F, Piali L, Spanaus KS, Seebach J, Fontana A. Chemokines and chemotaxis of leukocytes in infectious meningitis. J Neuroimmunol. 1998 May 1;85(1):33-43. (Pubitemid 28255435)
18. Bhowmick S, Duseja R, Das S, Appaiahgiri MB, Vrati S, Basu A. Induction of IP-10 (CXCL10) in astrocytes following Japanese encephalitis. Neurosci Lett. 2007 Feb 27;414(1):45-50. (Pubitemid 46241638)
19. Rupprecht TA, Koedel U, Angele B, Fingerle V, Pfster HW. [Cytokine CXCL13 a possible early CSF marker for neuroborreliosis]. Nervenarzt. 2006 Apr;77(4):470-3.
20. Rupprecht TA, Pfster HW, Angele B, Kastenbauer S, Wilske B, Koedel U. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology. 2005 Aug 9;65(3):448-50. (Pubitemid 41099810)
21. Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisäkk P, Ransohoff RM, Hofbauer M, Farina C, Derfuss T, Hartle C, Newcombe J, Hohlfeld R, Meinl E. Chemokines in mulitiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain. 2006 Jan;129(Pt 1):200-11. (Pubitemid 43063771)
22. McCandless EE, Piccio L, Woerner B, Schmidt RE, Rubin JB, Cross AH, Klein RS. Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis. Am J Pathol. 2008 Mar;172(3):799-808. (Pubitemid 351354551)
23. Giunti D, Borsellino G, Benelli R, Marchese M, Capello E, Valle MT, Pedemonte E, Noonan D, Albini A, Bernardi G, Mancardi GL, Battistini L, Uccelli A. Phenotypic and functional analysis of T cells homing into the CSF of subjects with infammatory diseases of the CNS. J Leukoc Biol. 2003 May;73(5):584-90. (Pubitemid 38040470)
24. Ljøstad U, Myglang A. CSF B-lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. J Neurol. 2008 May;255(5):732-7.